Q4 2022 Holdings
Filed 2023-02-14 | 8 holdings | $390.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Denali Therapeutics, Inc.(DNLI) | COM | 24823R105 | $102.0M | 3,668,749 | 26.1% |
| Karuna Therapeutics, Inc. | COM | 48576A100 | $100.8M | 512,872 | 25.8% |
| Eqrx, Inc. | COM | 26886C107 | $89.4M | 36,335,375 | 22.9% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $47.6M | 11,055,554 | 12.2% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $38.9M | 2,008,809 | 10.0% |
| Singular Genomics Systems, Inc. | COM | 82933R100 | $7.6M | 3,798,926 | 2.0% |
| Unity Biotechnology, Inc.(UNBX) | COM | 91381U200 | $2.8M | 1,004,817 | 0.7% |
| Metacrine, Inc. | COM | 59101E103 | $1.3M | 2,940,503 | 0.3% |